The Covid-19 pandemic can't hold down global drug spending, IQVIA reports, with cash expected to keep flowing
Despite its long-reaching effects in global markets, the Covid-19 pandemic is not expected to broadly impact global sales on medicines in the near-term future, according to a new report from IQVIA.
Over the next five or so years, through 2025, global spending will grow at an estimated 3% to 6% rate annually and reach $1.6 trillion in sales. Notably, that figure does not include an additional $157 billion expected to be spent on Covid-19 vaccines, which will mostly come from now through the end of 2022.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
